Published: October 6, 2015
The Multinational FLOW trial, a major global effort enrolling over 2500 patients, and led by the Orthopaedic Research Team at McMaster was unveiled at this year’s OTA meeting—San Diego. This was coupled with the simultaneous publication of the paper with NEJM on October 8th—to match the day of presentation.
Dr. Bhandari opened the session infront of one thousand surgeons at this year’s meeting. “I was simply in awe of the support and the interest in FLOW” said Bhandari. “It was a wonderful place to share the news for the first time”.
Heralded by the orthopaedic community as a “remarkable accomplishment”, the results were both surprising and practice-changing.
To learn more about the FLOW trial click here.